isoguvacine has been researched along with Cancer of Prostate in 2 studies
isoguvacine: A GABA agonist; RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, W | 1 |
| Yang, Q | 1 |
| Fung, KM | 1 |
| Humphreys, MR | 1 |
| Brame, LS | 1 |
| Cao, A | 1 |
| Fang, YT | 1 |
| Shih, PT | 1 |
| Kropp, BP | 1 |
| Lin, HK | 1 |
| Abdul, M | 1 |
| Mccray, SD | 1 |
| Hoosein, NM | 1 |
2 other studies available for isoguvacine and Cancer of Prostate
| Article | Year |
|---|---|
Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
Topics: Autocrine Communication; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; GABA Agonists; GABA A | 2014 |
Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer.
Topics: Bicuculline; Cell Proliferation; Colonic Neoplasms; Dihydroergotoxine; GABA Agonists; GABA Antagonis | 2008 |